C
CNS Pharmaceuticals, Inc. (CNSP)
NCM – Real vaqt narxi. Valyuta: USD
3.98
-0.17 (-4.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.98
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
3.98
-0.17 (-4.14%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
3.98
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:10 PM EDT
CNS Pharmaceuticals, Inc., klinik farmatsevtika kompaniyasi, Qo'shma Shtatlarda nevrologiya va onkologiya kasalliklari uchun terapiyalarni ishlab chiqish bilan shug'ullanadi. U TPI 287 ni ishlab chiqadi, bu tadqiq qilinayotgan kimyoterapiya vositasidir, u glioblastoma, miya metastazlari bilan metastatik ko'krak bezi saratoni, mayda hujayrali o'pka saratoni, kastratsiyaga chidamli prostata saratoni va neyroblastoma davolash uchun II bosqich klinik sinovdan o'tmoqda; va Berubicin, tadqiq qilinayotgan antatsiklin kimyoterapiya vositasidir, u glioblastoma va miya o'smalarini davolash uchun II bosqich klinik sinovdan o'tmoqda. Kompaniya 2017 yilda tashkil etilgan va shtab-kvartirasi Xyustonda, Texasda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. E. Lynne Kelley F.A.C.S., M.D. | Chief Medical Officer |
| Mr. Christopher S. Downs CPA, CTP, FP&A | Senior Vice President of Finance |
| Mr. Dylan Wenke M.B.A. | Chief Business Officer |
| Mr. Eric Faulkner M.B.A., M.Sc. | Chief Technology Officer |
| Mr. Rami Levin M.B.A. | President, CEO & Director |
| Mr. Steve O'Loughlin M.B.A. | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-19 | S-3 | cns_s3.htm |
| 2026-05-19 | D | |
| 2026-05-14 | 10-Q | cns_i10q-033126.htm |
| 2026-05-04 | 8-K | cns_8k.htm |
| 2026-04-30 | 10-K/A | cns_i10ka1-123125.htm |
| 2026-03-31 | 10-K | cns_i10k-123125.htm |
| 2026-03-11 | 8-K | cns_8k.htm |
| 2026-03-02 | 8-K | cns_8k.htm |
| 2026-02-27 | S-8 | cns_s8.htm |
| 2026-02-17 | 8-K | cns_8k.htm |